tiprankstipranks
Trending News
More News >

ASKA Pharmaceutical Announces Third Quarter FY2024 Financial Results

Story Highlights
ASKA Pharmaceutical Announces Third Quarter FY2024 Financial Results

Don’t Miss TipRanks’ Half-Year Sale

ASKA Pharmaceutical Holdings Co., Ltd. ( (JP:4886) ) has shared an update.

ASKA Pharmaceutical Holdings Co., Ltd. reported its consolidated financial results for the third quarter of FY2024, showing a slight increase in net sales to 49,926 million yen but a decrease in operating and ordinary profits. The profit attributable to owners of the parent dropped significantly by 36.5% compared to the previous year. Despite the decline in profits, the company’s total assets and equity ratio improved, indicating a stable financial position. The company has maintained its dividend forecast and expects a slight overall improvement in operating profit for the full fiscal year.

More about ASKA Pharmaceutical Holdings Co., Ltd.

ASKA Pharmaceutical Holdings Co., Ltd. is a company listed on the Tokyo Stock Exchange, focusing on the pharmaceutical industry. It is involved in the development and sale of pharmaceutical products and services.

YTD Price Performance: -6.29%

Average Trading Volume: 58,094

Technical Sentiment Consensus Rating: Hold

Current Market Cap: Yen55.89B

Learn more about 4886 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1